A first dengue infection usually passes without drama. A second one can behave differently. Here is what the evidence says about the mechanism, the warning signs, and the phase that matters most.
Dengue is common, and most cases are mild
Dengue is a viral infection spread to people by the bite of infected mosquitoes. The World Health Organization states that most people who get dengue have no symptoms at all. When symptoms do appear, they usually begin four to ten days after infection and last two to seven days. Typical signs include high fever near 40 degrees Celsius, severe headache, pain behind the eyes, muscle and joint pain, nausea, vomiting, swollen glands and a rash. Reported cases rose from just over half a million in 2000 to 14.6 million in 2024, with more than twelve thousand deaths that year. Between January and July 2025, over four million cases and more than three thousand deaths were reported across 97 countries.
There are four serotypes, and immunity is specific
Dengue is not one virus. The European Centre for Disease Prevention and Control describes four distinct dengue virus serotypes, DENV-1 to DENV-4, which share roughly 65 to 70 percent of their amino acid sequence. Infection gives long-term immunity against the same serotype but not against the other three. That detail explains why repeat infection is possible at all. It also explains why the second infection deserves attention rather than alarm. A person who has had DENV-1 can later be infected by DENV-2, DENV-3 or DENV-4. The immune memory from the first infection does not neutralise a different serotype. Instead, in some people, that older immune response interacts with the new virus in a way that changes the course of the illness.
Antibodies can help the virus instead of blocking it
Antibody-dependent enhancement is the name for this effect. The European Centre for Disease Prevention and Control calls it a key feature of dengue pathogenesis in later infections. Antibodies from a first infection that do not neutralise a different serotype bind to the new virus and form complexes. Receptors on immune cells recognise these complexes and facilitate viral entry. Viral uptake and replication increase, and the immune response becomes exaggerated. A study in Science followed 6684 Nicaraguan children with antibody data for twelve years from August 2004 to April 2016, covering 41302 samples and 618 dengue cases, after enrolling 8002 children aged two to fourteen. Children with pre-existing antibody levels of 1:21 to 1:80 had a 7.64-fold higher hazard of dengue haemorrhagic fever or dengue shock syndrome, with a 95 percent confidence interval of 3.19 to 18.28, compared with DENV-naive children.
The critical phase begins as the fever falls
The Pan American Health Organization divides dengue into three phases: febrile, critical and recovery. The febrile phase starts with a sudden high fever and lasts two to seven days, often with facial flushing, body pain, muscle pain, joint pain, headache and pain behind the eyes. The critical phase starts near the end of the fever, when the temperature drops to 37.5 degrees Celsius or below and stays there. This usually happens in the first three to seven days of illness, when capillary permeability can increase in parallel with haematocrit levels. The critical phase does not exceed 48 to 72 hours. Patients who worsen as the fever drops, and who show warning signs, are classified as having dengue with warning signs.
Warning signs that need urgent medical review
Warning signs are the practical signal that a case has moved out of the ordinary. The World Health Organization lists severe abdominal pain, persistent vomiting, rapid breathing, bleeding gums or nose, restlessness, blood in vomit or stool, and pale cold skin. The European Centre for Disease Prevention and Control adds lethargy, an enlarged liver and a rising haematocrit. These signs often appear after the fever has gone, which is exactly when a patient may feel falsely reassured. The Pan American Health Organization describes intense continuous abdominal pain, persistent vomiting, fluid accumulation, mucosal bleeding, altered consciousness, liver enlargement and a progressive rise in haematocrit as alarm signs. Urgent medical assessment is the right response to any of them, not waiting to see whether the next day is better.
Severe dengue and who is at higher risk
About ten percent of symptomatic cases may develop warning signs (ECDC). The European Centre for Disease Prevention and Control reports that about two to five percent of patients with warning signs progress to severe dengue. Severe dengue shows as plasma leakage leading to shock, severe bleeding, or serious organ impairment. The reported case fatality rate for dengue is usually below one percent, but severe dengue carries a substantially higher risk of death (ECDC). Risk factors include infancy and old age, conditions such as diabetes, asthma and hypertension, previous infection with dengue or related viruses like Zika, and the antigenic distance between the first and later infections. The Science study found that children with the lowest and highest antibody levels were least at risk, while a middle range carried the highest risk. That pattern shows why a second infection is not automatically severe.
Care, recovery and what to watch after the fever
There is no specific treatment for dengue. The World Health Organization states that pain can be managed with paracetamol, while ibuprofen and aspirin should be avoided because they can increase the risk of bleeding. Most people are viremic for about four to five days, though it can last as long as twelve. Fatigue may persist for several weeks after recovery. The Pan American Health Organization notes that the recovery phase brings a returning appetite, a stable circulation and increased urine output. Fluid overload is a risk if intravenous therapy has been excessive. Physical barriers such as intact, correctly specified and correctly used mosquito nets remain real protection. If warning signs appear, seek medical care promptly.
Sources
- Dengue: World Health Organization
- Factsheet for health professionals about dengue: European Centre for Disease Prevention and Control
- Dengue: Symptoms, Prevention and Treatments - PAHO/WHO: Pan American Health Organization
- Antibody-dependent enhancement of severe dengue disease in humans: Science via PubMed Central
This article is general information, not medical advice. Ask a doctor or pharmacist about your own health.